Using database species SNPs as IVs, we integrated a large number of 2-sample MR methods to show that 2 immune cell types, HLA-DR on CD14+ monocytes and CD39+ CD4+ T cells, were associated with IBD risk. Here, CD4 is linked to inflammatory bowel disease.